Fierce Biotech – LUMICKS snags £93M for its molecular tweezers and cell therapy hardware
https://www.fiercebiotech.com/medtech/lumicks-snags-93m-for-its-molecular-tweezers-and-cell-therapy-hardware?mkt_tok=Mjk0LU1RRi0wNTYAAAF8igMUtlBIdahGhfVHfuZPT8bUmAzF958avUNCMmYQPPwgnw3eLOiQb00C2v7YWrzTxX8oHSuJt1FeAy4gqwI9f7Ys6DBkgiBJPLEAkfh24wWuKwQ&mrkid=936965Articles récents
- Lauxera Capital Partners Invests in Bridge To Life to Back the Next Chapter in Organ Preservation
- Lauxera Capital Partners Invests in GenePlanet to Drive Global Diagnostics Expansion
- L’industrie Medtech, terrain de jeu idéal pour le capital-investissement – Décideurs Magazine – Paroles d’experts
- Lauxera collecte 520 m€ dans la healthtech – Les Echos – Capital Finance
- Lauxera Capital closes €520M fundraising to propel European medtech – Mugglehead
Commentaires récents
No comments to show.